Ovarian Cancer

Ovarian Cancer: Second Edition  eBooks & eLearning

Posted by AvaxGenius at June 10, 2017
Ovarian Cancer: Second Edition

Ovarian Cancer: Second Edition By M. Sharon Stack, David A. Fishman
English | PDF | 2010 | 2009 | 411 Pages | ISBN : 0387980938 | 9 MB

Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics.

Clinical Trials in Ovarian Cancer  eBooks & eLearning

Posted by readerXXI at March 25, 2017
Clinical Trials in Ovarian Cancer

Clinical Trials in Ovarian Cancer
by Christine S. Walsh
English | 2017 | ISBN: 081358647X | 336 Pages | PDF | 1.91 MB

The first book to organize this cutting-edge research into an easy-to-use reference, Clinical Trials in Ovarian Cancer should help medical personnel at all levels provide their patients with the highest standard of care.

Bethany R. Collier - Handbook on Ovarian Cancer: Risk Factors, Therapies and Prognosis  eBooks & eLearning

Posted by rotten comics at Oct. 24, 2016
Bethany R. Collier - Handbook on Ovarian Cancer: Risk Factors, Therapies and Prognosis

Bethany R. Collier - Handbook on Ovarian Cancer: Risk Factors, Therapies and Prognosis
2015 | ISBN: 1634838742 | English | 264 pages | PDF | 2.7 MB

Ovarian Cancer in Elderly Patients  eBooks & eLearning

Posted by roxul at March 24, 2016
Ovarian Cancer in Elderly Patients

Gilles Freyer, "Ovarian Cancer in Elderly Patients"
English | ISBN: 3319235877 | 2016 | 300 pages | PDF | 2 MB

Surgery for Ovarian Cancer: Principles and Practice, Second Edition (repost)  eBooks & eLearning

Posted by libr at March 8, 2016
Surgery for Ovarian Cancer: Principles and Practice, Second Edition (repost)

Surgery for Ovarian Cancer: Principles and Practice, Second Edition by Robert E. Bristow and Beth Y. Karlan
English | 2010 | ISBN: 1841847062 | 460 pages | PDF | 38 MB

"Ovarian Cancer: Clinical and Therapeutic Perspectives " ed. by Samir Farghaly  eBooks & eLearning

Posted by exLib at Feb. 23, 2016
"Ovarian Cancer: Clinical and Therapeutic Perspectives " ed. by Samir Farghaly

"Ovarian Cancer: Clinical and Therapeutic Perspectives " ed. by Samir Farghaly
ITAe | 2012 | ISBN: 9789533078106 | 348 pages | PDF | 28 MB

This book provides an analysis of current research into aspects of malignant transformation, growth control, and metastasis. A comprehensive spectrum of topics is covered providing up to date information on scientific discoveries and management considerations.

Patients' Guide to Ovarian Cancer  eBooks & eLearning

Posted by nebulae at Oct. 8, 2015
Patients' Guide to Ovarian Cancer

Robert Bristow, "Patients' Guide to Ovarian Cancer"
English | ISBN: 0763774375 | 2011 | 120 pages | PDF | 1 MB
Confronting Hereditary Breast and Ovarian Cancer: Identify Your Risk, Understand Your Options, Change Your Destiny (repost)

Confronting Hereditary Breast and Ovarian Cancer: Identify Your Risk, Understand Your Options, Change Your Destiny by Sue Friedman, Rebecca Sutphen, Kathy Steligo
English | ISBN: 1421404087, 1421404079 | 2012 | EPUB + MOBI | 288 pages | 3 + 2 MB

Memoir of a Debulked Woman: Enduring Ovarian Cancer  eBooks & eLearning

Posted by happy4all at Aug. 22, 2015
Memoir of a Debulked Woman: Enduring Ovarian Cancer

Memoir of a Debulked Woman: Enduring Ovarian Cancer By Susan Gubar
2013 | 320 Pages | ISBN: 0393345890 , 0393073254 | EPUB | 1 MB

Intraperitoneal Therapy for Ovarian Cancer by David Alberts [Repost]  eBooks & eLearning

Posted by tanas.olesya at July 30, 2015
Intraperitoneal Therapy for Ovarian Cancer by David Alberts [Repost]

Intraperitoneal Therapy for Ovarian Cancer by David Alberts
English | Nov. 4, 2010 | ISBN: 3642121292, 3642423574 | 1563 Pages | PDF | 3 MB

Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials.